Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Conference highlights Biomarker Detection Role for NanoSight

The NanoSight NS500 system like the one being used in Oxford by the Sargent group
The NanoSight NS500 system like the one being used in Oxford by the Sargent group

Abstract:
Researchers from Oxford have recently presented exciting new data applying nanoparticle tracking analysis (NTA) to size and count both cellular microvesicles and exosomes at a low concentration and, when used in conjunction with fluorescent labels, to selectively determine and analyse specific types of vesicle within a complex sample. This took place during a two-day conference in Oxford, "Micro and Nanovesicles in Health and Disease", organised by Dr Paul Harrison from the Oxford Haemophilia & Thrombosis Centre at the Churchill Hospital in Oxford and Ian Sargent, Professor of Reproductive Science in the Nuffield Department of Obstetrics and Gynaecology, University of Oxford.(1)

Conference highlights Biomarker Detection Role for NanoSight

Salisbury, UK | Posted on October 6th, 2010

Most researchers concur that the high levels of microvesicles and/or exosomes are associated with (i.e. potential biomarkers for) thrombotic diseases, cardiovascular disease and some cancers. Leading the research at the Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Professor Ian Sargent says "many cells shed small vesicles in a regulated way which plays a key role in intercellular communication. In general, there are two types of vesicle: microvesicles (100nm - 1 µm in diameter) which directly bud from the plasma membrane and nanovesicles (exosomes 30nm - 100nm) which are released by exocytosis from multivesicular bodies of the endosome. Both are involved in cell signalling. They carry diverse membrane and cytosolic proteins as well as messenger and microRNAs. They can affect the physiology of their target cells in various ways, from inducing intracellular signalling following binding to receptors, to conferring new properties after the acquisition of new receptors, enzymes or genetic material by fusion or endocytosis. They participate in physiological processes including haemostasis and thrombosis, inflammation, immune interactions and angiogenesis.

Continuing, Sargent said: "NanoSight's NTA technique is a major step forward in analytical capability taking the limits of flow cytometry down almost an order of magnitude. It is rapid and, in common with flow cytometry, characterizes polydispersity well."

Also at this conference Edwin van der Pol from the Academic Medical Center at the University of Amsterdam presented a theoretical comparison of analytical techniques for microvesicles and exosomes. This confirmed the advantages of using NTA for studying vesicles sized from 50-400nm. The previously preferred technique was flow cytometry. However, van der Pol concluded this has a practical lower limit of 300nm. Similarly electrozone sensing is not able detect at such small sizes. He added that while Dynamic Light Scattering (DLS) is able to identify very small particles, it generally biases towards large particles in polydisperse samples so this mis-reporting renders it of little value. It is also not able to make concentration measurement.

Jeremy Warren, NanoSight CEO, commented "The work of this important group is a significant milestone for us. It is the first step toward directing NanoSight's capability as a platform for biomarker detection".

In the closing session, Dr Karl Morten, also from University of Oxford, described NanoSight's useful role in rapidly assessing newly developed nanoparticles, as he summarised a range of roles of nanotechnology in drug delivery.

This conference bought together 135 delegates in this rapidly growing area of interest. There were five groups from the UK, Netherlands and USA who have recently added NanoSight's NTA to their characterisation capability.

To learn more about nanoparticle characterization using Nanoparticle Tracking Analysis, NTA, please visit the company website (www.nanosight.com) and register for the latest issue of NanoTrail, the company's electronic newsletter.

Reference:

(1) Nanoparticle Tracking Analysis for the Measurement and Characterisation of Cellular Microvesicles and Nanovesicles, Proc NVTH BSTH 2010

####

About NanoSight Limited
NanoSight Limited, of Salisbury, UK, provides unique nanoparticle characterization technology. “Nanoparticle Tracking Analysis” (NTA) detects and visualizes populations of nanoparticles in liquids down to 10nm (material dependent) and measures the size of each particle from direct observations of diffusion. This particle-by-particle methodology goes beyond traditional light scattering techniques such as Dynamic Light Scattering (DLS), or Photon Correlation Spectroscopy (PCS), in providing high-resolution particle size distributions. Additionally NanoSight measures concentration and validates all data with video of particles moving under Brownian motion.

This characterization information is highly informative in understanding the more complex suspensions in biological systems, hence its wide application in development of drug delivery systems, viral vaccines, the study of toxicology of nanoparticles and their environmental fate and in biomarker detection. This real-time data also provides insight into the kinetics of protein aggregation and other time-dependent phenomena in a quantitative manner, at deeply sub-micron sizes.

NanoSight has more than 250 systems installed worldwide with users including BASF, BP, GlaxoSmithKline, Novartis, 3M Corp., Roche, Solvay and Unilever together with many universities and research institutes. There are currently 100+ third party papers citing NanoSight results, with this reference base growing very rapidly as NanoSight consolidates its key contribution to nanoparticle characterization. For more information, visit the NanoSight website (www.nanosight.com).

For more information, please click here

Contacts:
NanoSight Limited
Minton Park
London Road
Amesbury SP4 7RT
T +44 (0) 1980 676060
F +44 (0) 1980 624703


NetDyaLog Limited
39 de Bohun Court
Saffron Walden
Essex CB10 2BA
T +44 (0) 1799 521881
M +44 (0) 7843 012997

Copyright © NanoSight Limited

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Guo Lab Shows Potential of RNA as Heat-resistant Polymer Material for Nanoarchitectures April 23rd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

Academic/Education

Global leader in solar cell manufacturing eyes New York for major expansion outside of Japan: CNSE and Solar Frontier Explore $700 Million Investment, Job Creation in New York State April 22nd, 2014

University of Waterloo Visits China to Strengthen Bonds With Research Partners April 21st, 2014

Director Wally Pfister joins UC Berkeley neuroengineers to discuss the science behind ‘Transcendence’ April 7th, 2014

First annual science week highlights STEM pipeline and partnerships: UB, SUNY Buffalo State and ECC team up with the City of Buffalo and its schools for April 7-11 events April 3rd, 2014

Nanomedicine

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

Cloaked DNA nanodevices survive pilot mission: Successful foray opens door to virus-like DNA nanodevices that could diagnose diseased tissues and manufacture drugs to treat them April 22nd, 2014

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

Amino-functionalized carbon nanotubes act as a carrier for nerve growth factor April 21st, 2014

Announcements

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Guo Lab Shows Potential of RNA as Heat-resistant Polymer Material for Nanoarchitectures April 23rd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

Tools

MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014

Oxford Instruments Asylum Research Introduces the MFP-3D InfinityTM AFM Featuring Powerful New Capabilities and Stunning High Performance April 18th, 2014

More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014

Scientists Capture Ultrafast Snapshots of Light-Driven Superconductivity: X-rays reveal how rapidly vanishing 'charge stripes' may be behind laser-induced high-temperature superconductivity April 16th, 2014

Events/Classes

PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

'Life Redesigned: The Emergence of Synthetic Biology' Lecture at Brookhaven Lab on Wednesday, April 30: Biomedical Engineer James Collins to Speak for BSA Distinguished Lecture Series April 16th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE